Facebook X (Twitter) Instagram
    Facebook Instagram Threads
    Global BiodefenseGlobal Biodefense
    Subscribe
    • Featured News
    • Funding
    • Directory
    • Jobs
    • Events
    Global BiodefenseGlobal Biodefense
    Antimicrobial Resistance

    JPM-TMT Seeks Solutions to Multi-Drug Resistant Biowarfare Agents

    By Global Biodefense StaffMarch 12, 2013
    Share
    Facebook LinkedIn Reddit Email

    Yersinia pestis (Plague)The U.S. Department of Defense has initiated a new research and development effort to address the continuing emergence of multi-drug resistant bacteria and advancements in biotechnology that enable development of genetically engineered, drug-resistant bacteria. 

    To address the potential weaponization of multi-drug resistant biological warfare agents the Joint Project Manager Transformational Medical Technologies (JPM-TMT) has issued a Request for Information (RFI) for therapeutic solutions including development of: 

    • Novel combinations of existing FDA-approved therapeutics that act synergistically
    • Adjunctive molecules that interfere with antibiotic resistance mechanisms
    • Novel therapeutic compounds for which there is no known bacterial resistance 

    Medical countermeasures against Yersinia pestis, Brucella, Francisella tularensis, Burkholderia mallei and pseudomallei are specifically sought. 

    The effort is spearheaded by JPM-TMT’s provisional Countermeasures for Multi-Drug Resistance—Bacterial (CMDR-B) program. Further details are available under Solicitation Number: HDTRA1-RFI-TMT01. The response deadline is May 17, 2013. 

    Source: JPM-TMT, FBO.gov 

    Image: Dark stained bipolar ends of Yersinia pestis can clearly be seen in this Wright’s stain of blood from a plague victim (CDC)

    Antimicrobials Brucella Burkholderia Defense Threat Reduction Agency F. tularensis JPEO-CBRND RFI Y. pestis
    Share. Facebook LinkedIn Reddit Email
    Previous ArticleIndia Completes First Biodefense Level 4 Lab
    Next Article Advancing Biodosimetry for Radiation Exposure Triage and Treatment

    Related Stories

    EPA Developing AMR Risk Framework for Antibacterial and Antifungal Pesticides

    September 29, 2023

    Jurata Thin Film and CastleVax Awarded Grant to Advance Thermostabilized COVID-19 Booster

    September 20, 2023

    Mount Sinai to Lead Development of Pan-Coronavirus Vaccine Under New Federal Grant

    September 17, 2023

    NIAID Seeks to Improve Computational Models of Influenza Immunity

    September 15, 2023
    News Scan

    Biodefense Headlines – 19 September 2023

    News Scan September 19, 2023

    News highlights on health security threats and countermeasures curated by Global Biodefense This week’s selections include a global survey of gain-of-function research; funding of an mRNA mpox vaccine; Nipah virus outbreak in India; field detection of threat agents with acoustic…

    Upcoming Events

    Oct 3
    Virtual Event Virtual Event
    October 3 - October 5

    OneLab Summit 2023

    Oct 3
    Virtual Event Virtual Event
    12:00 pm - 2:00 pm EDT

    Public-Private Partnerships to Distribute, Dispense, and Administer Medical Countermeasures

    Oct 4
    Virtual Event Virtual Event
    10:00 am - 2:00 pm EDT

    Tunneling Nanotubes and Intracellular Protrusions Workshop

    Oct 12
    Virtual Event Virtual Event
    12:00 pm - 2:00 pm EDT

    Public-Private Partnerships for Acceptance and Uptake of Medical Countermeasures

    View Calendar

    Subscribe to Global Biodefense

    Get the latest news on pathogens and preparedness

    © 2023 Stemar Media Group LLC
    • About
    • Contact
    • Privacy
    • Subscribe

    Type above and press Enter to search. Press Esc to cancel.

    We use cookies to ensure that we give you the best experience on our website. If you continue to use this site we will assume that you are okay with it.OkPrivacy policy